Literature DB >> 29066169

Genotypes of IFIH1 and IFIT5 in seven chicken breeds indicated artificial selection for commercial traits influenced antiviral genes.

Jing-Jing Li1, Ye Wang1, Chao-Wu Yang2, Jin-Shan Ran1, Xiao-Song Jiang2, Hua-Rui Du2, Yao-Dong Hu1, Yi-Ping Liu3.   

Abstract

Innate immunity is the first line against the invasion of pathogenic microorganisms. Previous reports only demonstrated production traits of commercial importance were often negatively correlated with innate disease resistance. However, whether different purpose of artificial selection influences innate immunity have not been understood. In this study, we cloned exon1, exon6 of IFIH1 and exon2 of IFIT5 by molecular biology techniques in seven different chicken breeds to detect the potential effect of artificial selection for commercial traits on disease resistance for the first time. In total, 8 single nucleotide polymorphisms(SNPs) of IFIH1 gene exon1 and exon6, 19 SNPs of IFIT5 gene exon2 were detected. We found all native chicken breeds had a relatively close relationship to broiler breeds but a remote relationship to layer breed. A great difference between CB and LLH with different selected purpose were observed. The allele frequencies of these two positive antiviral genes were associated with different purpose of artificial selection. Our experiment constituted the foundation for the interaction between commercial traits and immune trait.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Commercial traits; Disease resistance; IFIH1; IFIT5; Polymorphisms

Mesh:

Substances:

Year:  2017        PMID: 29066169     DOI: 10.1016/j.meegid.2017.10.019

Source DB:  PubMed          Journal:  Infect Genet Evol        ISSN: 1567-1348            Impact factor:   3.342


  1 in total

1.  Genotype frequency contributions of Mx1 gene in eight chicken breeds under different selection pressures.

Authors:  Jingjing Li; Chaowu Yang; Jinshan Ran; Xiaosong Jiang; Huarui Du; Zhiqiang Li; Yiping Liu; Long Zhang
Journal:  3 Biotech       Date:  2018-11-14       Impact factor: 2.406

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.